A Multifunctional Hydrogel Delivers Gold Compound and Inhibits Human Lung Cancer Xenograft
Interpenetrating network system (IPN), consisting of polyethylene glycol (PEG) –diacrylate (PEGdA) and modified gelatin, is a biocompatible and biodegradable hydrogel and has been studied for the local delivery of bioactive molecules and drugs. Gold(III) porphyrin(AuP) is a stable metal compound in the development for anticancer application when administered systemically. The aim of this work is to develop a novel formulation for AuP based on IPN for local delivery.
IPN loaded with AuP hydrogel was optimized and synthesized. Drug release kinetics, cytotoxicity against tumor cells, and antitumor activity in lung cancer bearing nude mice were studied.
AuP released from the IPN followed a first order kinetics in vitro. The AuP loaded IPN showed higher cytotoxicity against human lung cancer cell lines compared to IPN only. In mice bearing human lung cancer xenograft, AuP loaded IPN inhibited tumor growth and reduced angiogenesis. No sign of systemic toxicity was observed for all treatment groups.
AuP loaded IPN provides an improved formulation over systemic delivery for tumor inhibition to complement surgical intervention.
Key wordscancer gel-PEG-Cys gold porphyrin in situ interpenetrating network system (IPN)
- 2.[Internet] World Health Organization (Feb 2018). Fact sheets. Retrieved from http://www.who.int/mediacentre/factsheets/fs297/en/
- 5.[Internet] American Cancer Society (May 2018). https://www.cancer.org/cancer/non small-cell-lung-cancer/about/what-is-non-small-cell-lung-cancer.html.
- 6.Yegya-Raman N, Zou W, Nie K, Malhotra J, Jabbour SK. Advanced radiation techniques for locally advanced non-small cell lung cancer: intensity-modulated radiation therapy and proton therapy. J Thorac Dis 2018;10(Suppl 21):S2474-S91, S2491.Google Scholar
- 8.Wu W, Chen H, Shan F, Zhou J, Sun X, Zhang L, et al. A novel doxorubicin-loaded in situ forming gel based high concentration of phospholipid for intratumoral drug delivery. Mol Pharm. 2014;11(10):3378–85.Google Scholar
- 15.Che CM, Sun RW, Yu WY, Ko CB, Zhu N, Sun H. Gold(III) porphyrins as a new class of anticancer drugs: cytotoxicity, DNA binding and induction of apoptosis in human cervix epitheloid cancer cells. Chem Commun (Camb). 2003;(14):1718–9.Google Scholar
- 25.Hu D, Liu Y, Lai YT, Tong KC, Fung YM, Lok CN, et al. Anticancer gold(III) porphyrins target mitochondrial chaperone Hsp60. Angew Chem Int Ed Engl. 2016;55(4):1387–91.Google Scholar
- 27.Kim JH, Kim MS, Lee BH, Kim JK, Ahn EK, Ko HJ, et al. Marmesin-mediated suppression of VEGF/VEGFR and integrin beta1 expression: its implication in non-small cell lung cancer cell responses and tumor angiogenesis. Oncol Rep. 2017;37(1):91–7.Google Scholar
- 35.Xu K, Fu Y, Chung W, Zheng X, Cui Y, Hsu IC, et al. Thiol-ene-based biological/synthetic hybrid biomatrix for 3-D living cell culture. Acta Biomater. 2012;8(7):2504–16.Google Scholar
- 37.Waldeck H, Kao WJ. Effect of the addition of a labile gelatin component on the degradation and solute release kinetics of a stable PEG hydrogel. J Biomat Sci-Polym E. 2012;23(12):1595–611.Google Scholar
- 42.Lee P, Zhang R, Li V, Liu X, Sun RW, Che CM, et al. Enhancement of anticancer efficacy using modified lipophilic nanoparticle drug encapsulation. Int J Nanomedicine. 2012;7:731–7.Google Scholar
- 43.He L, Chen T, You Y, Hu H, Zheng W, Kwong WL, et al. A cancer-targeted nanosystem for delivery of gold(III) complexes: enhanced selectivity and apoptosis-inducing efficacy of a gold(III) porphyrin complex. Angew Chem Int Ed Engl. 2014;53(46):12532–6.Google Scholar